Breaking News, Promotions & Moves

BerGenBio Names New CEO

Olav Hellebø brings a wealth of experience as a leader in pharmaceutical and biotechnology companies.

Author Image

By: Charlie Sternberg

Associate Editor

BerGenBio ASA, a clinical-stage biopharmaceutical company, has appointed Olav Hellebø as CEO.   Hellebø boasts three decades of experience in the pharmaceutical and biotechnology industries. Since 2023, he has served as board director in the clinical stage immuno-oncology company Cytovation ASA, and since 2021, he has been a board director at the clinical-stage biopharmaceutical company Antev Ltd, specializing in urology and oncology treatments.   Hellebø’s prior experience also includ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters